Castle Biosciences CSTL Cash Flow Statement (2018-2026)

NASDAQ CSTL
$33.79 -0.71 (-2.06%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Castle Biosciences Quarterly Cash Flow Statement

Periods 34 quarters
Latest Sep 2026

Castle Biosciences reported cash from operations of $19.74M and free cash flow of $12.25M for the quarter ended Sep 2026, down 12.8% year over year. This cash flow statement covers 34 quarters of results from Jun 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-6.43M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.52M-0.50M-2.33M-14.52M-2.06M-4.10M
Depreciation and DepletionDep. & Depletion
0.44M0.50M0.53M0.62M0.63M0.67M0.79M0.90M0.95M1.09M1.10M1.27M1.43M1.44M1.45M1.54M1.50M1.70M1.82M2.08M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
1.45M2.15M2.63M2.92M2.84M2.89M3.04M3.17M3.22M3.34M3.35M3.54M5.77M29.76M3.41M3.82M3.78M3.93M4.07M4.18M
Share-based CompensationStock Comp.
6.85M8.42M8.78M9.20M9.92M13.53M12.85M13.04M11.80M12.68M13.18M13.03M11.44M11.18M11.21M12.10M11.41M9.78M11.59M11.23M
Deferred Taxes
-8.74M0.12M-1.96M-0.04M0.01M-0.24M-1.54M5.25M-2.31M-0.77M-4.67M0.12M-0.91M-0.01M0.00M0.08M
Gains from Investment SecuritiesGains Investment
0.56M-1.43M1.19M3.56M-1.86M2.02M-0.63M-3.43M
Other non-cash itemsOther Non-Cash
0.10M2.57M-20.40M-0.15M-0.33M0.21M0.35M0.18M-0.10M0.13M0.06M0.03M0.19M0.06M-0.13M0.53M0.24M0.14M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.46M2.73M2.90M0.05M0.54M4.38M3.60M5.80M1.15M4.26M3.36M4.25M0.77M5.22M-3.91M-1.91M-6.27M-1.08M5.82M3.36M
Change in InventoryChange Inventory
-0.36M0.33M0.74M0.44M0.18M0.54M1.60M-0.35M2.17M-0.30M0.37M-1.44M1.56M-1.29M1.52M0.31M1.60M0.21M0.12M-0.20M
Change in Account PayablesChange Payables
-0.86M0.19M0.12M1.85M-1.57M3.90M-0.83M-0.38M3.01M-0.42M-1.23M-2.15M-0.57M0.62M1.07M1.41M-0.02M3.19M-2.31M1.39M
Change in Accrued ExpensesChange Accrued Exp.
3.20M-6.92M8.03M2.56M4.83M-11.56M4.50M5.11M6.54M-14.24M6.53M6.43M4.88M-14.70M7.12M9.48M3.83M-19.18M7.78M18.02M
Change in Other Operating AssetsOther Assets Change
-1.65M0.09M-0.33M0.88M-1.03M0.00M0.39M1.55M-0.91M-0.01M-0.52M1.24M-1.15M2.98M1.06M-0.47M-4.04M6.83M0.91M1.00M
Change in Other Operating LiabilitiesOther Liabilities Change
-3.49M-0.23M-0.22M-0.11M-0.05M-0.07M1.03M0.14M-0.24M-0.25M-0.18M-0.43M-0.43M-0.53M-0.34M-0.20M-0.21M-0.17M-0.06M0.09M
Other Working Capital ChangesOther WC Changes
-1.84M-0.32M0.11M-0.99M0.98M-0.01M-0.10M-7.00M-0.97M
Cash from OperationsCash from Ops.
-2.78M-21.43M-9.00M-5.22M-6.00M-25.44M-3.79M5.01M18.59M-6.84M24.00M23.34M24.37M-6.04M20.82M22.63M26.93M-22.13M15.20M19.74M
Investing Activities
Capital ExpendituresCapex
-32.29M0.40M1.41M2.04M1.79M3.34M4.04M2.46M3.79M9.15M5.23M6.38M7.57M4.74M9.26M14.83M7.18M12.46M8.65M7.49M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M0.01M0.00M0.19M0.01M0.00M0.00M0.00M0.01M0.00M0.00M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Change in Property, Plant and EquipmentChange in PP&E
32.30M-0.40M-1.40M-2.04M-1.60M-3.33M-4.03M-2.45M-3.79M-9.15M-5.23M-6.37M-7.56M-4.73M-9.25M-14.82M-7.18M-12.45M-8.64M-7.48M
Acquisitions
0.31M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.31M
Purchase of InvestmentsInvestments Purchased
5.57M
Sale and Maturity of InvestmentsInvestments Sold
50.00M45.00M43.00M48.50M50.20M36.25M36.80M60.65M36.30M44.00M54.90M55.53M41.78M41.57M58.70M
Cash from Investing ActivitiesCash from Investing
-30.89M-0.40M-27.51M-134.15M-4.48M16.58M-15.39M-9.71M-7.67M-19.70M-21.42M-14.79M5.77M-22.43M-28.38M-18.39M8.83M-25.80M-15.96M-4.73M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
10.00M
Long-Term Debt RepaymentsLT Debt Repayment
0.01M0.02M0.03M0.03M0.03M0.04M0.04M0.04M0.04M0.04M0.01M0.02M0.03M0.03M0.03M0.03M0.03M0.02M0.02M0.03M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.01M-0.02M-0.03M-0.03M-0.03M-0.04M-0.04M-0.04M-0.04M9.96M-0.01M-0.02M-0.03M-0.03M-0.03M-0.03M-0.03M-0.02M-0.02M-0.03M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.01M-0.02M-0.03M-0.03M-0.03M-0.04M-0.04M-0.04M-0.04M9.96M-0.01M-0.02M-0.03M-0.03M-0.03M-0.03M-0.03M-0.02M-0.02M-0.03M
Change in Capital Stock
Common Stock IssuedStock Issued
0.92M1.30M0.72M0.47M0.84M1.08M0.80M0.35M0.75M1.15M0.67M2.16M1.02M0.99M0.53M0.30M2.81M1.59M0.93M1.82M
Net Shares Issued and RepurchasedNet Shares Issued
0.92M1.30M0.72M0.47M0.84M1.08M0.80M0.35M0.75M1.15M0.67M2.16M1.02M0.99M0.53M0.30M2.81M1.59M0.93M1.82M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.92M1.30M0.72M0.47M0.84M1.08M0.80M0.35M0.75M1.15M0.67M2.16M1.02M0.99M0.53M0.30M2.81M1.59M0.93M1.82M
Other financing activities (as filed)
-0.78M-0.06M-0.03M-0.05M-1.55M-0.31M-0.53M-0.27M-4.02M-0.47M-0.62M-1.29M-6.38M-2.52M-0.59M-1.19M-7.37M-6.60M-1.79M-0.92M
Cash from Financing ActivitiesCash from Financing
0.13M1.22M0.66M0.39M-0.75M0.73M0.23M0.05M-3.30M10.64M0.04M0.84M-5.39M-1.55M0.10M-0.92M-4.59M-5.03M-0.89M0.87M
Additional items
Change in Cash
-33.54M-20.62M-35.85M-138.99M-11.23M-8.13M-18.95M-4.65M7.62M-15.89M2.62M9.39M24.75M-30.02M-7.46M3.32M31.17M-52.97M-1.65M15.88M
Beginning Cash Balance
409.85M329.63M329.63M329.63M329.63M122.95M122.95M122.95M122.95M98.84M98.84M98.84M98.84M119.71M119.71M119.71M119.71M116.73M116.73M116.73M
Ending Cash Balance
329.63M309.02M273.17M134.18M122.95M114.82M95.87M91.22M98.84M82.95M85.57M94.96M119.71M89.69M82.23M85.56M116.73M63.76M62.12M77.99M
Free Cash FlowFCF
29.51M-21.83M-10.41M-7.26M-7.79M-28.78M-7.82M2.56M14.79M-15.99M18.77M16.96M16.80M-10.78M11.56M7.80M19.75M-34.58M6.55M12.25M
Net Cash FlowNCF
-33.54M-20.62M-35.85M-138.99M-11.23M-8.13M-18.95M-4.65M7.62M-15.89M2.62M9.39M24.75M-30.02M-7.46M3.32M31.17M-52.97M-1.65M15.88M
Interest Paid
Income Taxes PaidTaxes Paid

Castle Biosciences Cash Flow Statement API

Pull Castle Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CSTL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY